Royalty Pharma
Buys drug royalties and funds late-stage medicines for future royalty streams.
$60.65
After-hours close−0.20 (−0.33%)
At close$60.85(−1.73%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 92.10%408.26M sharesInsiders 4.96%22.00M sharesOther 2.94%13.01M shares
Shares outstanding 443.27M · Float 415.02M · 93.6% free float
Institutions13F, as of Jun 30, 2026
655 holders · 408.26M shares · 110 new positions · 403 increased · 175 reduced · 54 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Morgan Stanley | 42.93M | 9.69% | −640.0K | Aug 13, 2026 |
| Capital International Investors | 35.27M | 7.96% | +268.0K | Aug 12, 2026 |
| BlackRock, Inc. | 27.83M | 6.28% | +1.93M | Aug 7, 2026 |
| FMR LLC | 24.51M | 5.53% | −638.4K | Aug 13, 2026 |
| State Street Corp | 12.34M | 2.78% | +1.35M | Aug 7, 2026 |
| Price T Rowe Associates Inc /MD/ | 11.19M | 2.53% | +9.26M | Aug 14, 2026 |
| Swedbank AB | 10.73M | 2.42% | −860.1K | Jul 15, 2026 |
| Baillie Gifford & Co | 10.02M | 2.26% | −6.14M | Aug 6, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Legorreta G. Pabloincl. Legorreta Investments, LLC | 18.73% | 101.79M | 13D | Aug 17, 2026 ↗ |
| Morgan Stanley | 9.20% | 38.91M | 13G | Aug 5, 2025 ↗ |
| Capital International Investors | 8.80% | 37.77M | 13G | May 14, 2026 ↗ |
| FMR LLC | 6.50% | 27.90M | 13G | Nov 5, 2025 ↗ |
| R & H Trust Co. (Guernsey) Limitedincl. Severgnini Achille G. | 5.70% | 24.22M | 13D | Feb 20, 2026 ↗ |
| BlackRock, Inc. | 5.70% | 25.45M | 13G | Feb 4, 2025 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Pablo G. Legorreta | director, officer: CEO, Chairman of the Board | 14.66M | 3.31% | Aug 7, 2026 |
| George W. Lloyd | officer: EVP, Investments & CLO | 1.94M | 0.44% | May 20, 2025 |
| Terrance P. Coyne | officer: EVP & CFO | 1.79M | 0.40% | Aug 7, 2026 |
| Christopher Hite | officer: EVP & Chairman, Partnering | 1.63M | 0.37% | Aug 19, 2026 |
| Marshall Urist | officer: EVP, Research & Investments | 1.36M | 0.31% | Aug 7, 2026 |
| Gregory Norden | director | 196.3K | 0.04% | Jun 8, 2026 |
| Errol B. Desouza | director | 81.4K | 0.02% | May 14, 2025 |
| Bonnie L. Bassler | director | 79.2K | 0.02% | Jun 30, 2026 |
| Henry A. Fernandez | director | 65.3K | 0.01% | Jun 30, 2025 |
| Ted W. Love | director | 58.4K | 0.01% | Jun 8, 2026 |
7 ten-percent owners hold 89.63M shares by Form 4, outside the officers-and-directors figure above · 6 people have not refiled in the last 18 months (5.45M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 18, 2026 | Christopher Hiteofficer: EVP & Chairman, Partnering | Sale | 100,000 | $59.97 | 370,401 |
| Aug 13, 2026 | Terrance P. Coyneofficer: EVP & CFO | Sale · 2 lots | 11,002 | $58.68 | 0 |
| Jul 1, 2026 | Marshall Uristofficer: EVP, Research & Investments | Sale | 9,099 | $55.88 | 0 |
| Jun 23, 2026 | Christopher Hiteofficer: EVP & Chairman, Partnering | Sale · 2 lots | 150,000 | $54.40 | 559,399 |
| Jun 24, 2026 | Marshall Uristofficer: EVP, Research & Investments | Sale | 9,098 | $55.18 | 9,099 |
| May 26, 2026 | Terrance P. Coyneofficer: EVP & CFO | Sale | 64,399 | $53.98 | 0 |
| May 20, 2026 | Marshall Uristofficer: EVP, Research & Investments | Sale | 13,684 | $52.75 | 18,197 |
| May 14, 2026 | Gregory Nordendirector | Sale | 3,045 | $53.00 | 191,803 |
| May 14, 2026 | Marshall Uristofficer: EVP, Research & Investments | Sale | 13,684 | $53.06 | 31,881 |
| Apr 28, 2026 | Terrance P. Coyneofficer: EVP & CFO | Sale · 2 lots | 34,791 | $49.78 | 0 |
CongressHouse and Senate disclosures
Not reported.